Can Charles River help you complete your IND program faster? Smarter? Better? Simply, yes. Having worked on 85% of the FDA’s approved drugs in 2019, we know how to design and execute successful IND programs. Our regulatory and scientific experts can help you minimize risk and ensure that your IND-enabling studies are done right, the first time, for maximum efficiency on the road to approval. Our comprehensive portfolio of integrated safety assessment services and global network of facilities ensures you satisfy even the most complex requirements on time and in budget.
Take the first step toward IND program success.
You've invested a lot of time, energy, and capital to bring your lead candidate this far.
Don't falter near the finish line.
Ensure the success of your IND application by choosing a proven partner who can deliver the bioanalysis, ADME, safety pharmacology, general toxicology, immunotoxicology, genetic toxicology studies, and SEND services you need to get your drug to the clinic.
Charles River can complete your program the right way, the first time. Mitigate risk, avoid delays, and achieve maximum ROI with a strategic, integrated approach to development.
As your IND partner, we'll guide you every step of the ay with our deep science, knowledge of evolving regulations, and sophisticated testing capabilities that produce the data you need to satisfy requirements on time and in budget.